Gili Pro BioSensor (also known as Gili BioSensor System)

by ContinUse Biometrics (also known as Donisi Health)  · Based in Israel → — Contact-free health detection works free from wires, wearables, and patches. Our patented AI-based system detects and analyzes multiple health bio-indicators simultaneously, delivering clinically meaningful insights and notifications of changes in key health indicators.
Cardiology Critical Care Pulmonology

Regulatory Status Disclosed

Overview

ContinUse Biometrics, also known as Donisi Health, develops a unique optical sensing unit and data platform that captures medical-grade physiological information remotely, without any physical contact. The core technology, exemplified by the Gili Pro BioSensor (also known as “Gili BioSensor System”), utilizes patented methods for nano-level detection and analysis of vibrations associated with the movement of internal organs and molecules. The system employs an optical sensor and advanced AI algorithms to obtain and analyze video signals, estimating biomedical parameters such as heart rate and respiratory rate. This data is streamed to a health cloud, providing unique and actionable insights to end-users. The device is designed for use by or under the supervision of healthcare professionals for adult patients in various medical care settings, including hospitals and outpatient clinics, as well as for clinical research purposes. It functions as a spot-measurement tool and is not intended for continuous vital signs monitoring or as an apnea monitor.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Contactless biometric sensing
  • Measures heart rate
  • Measures respiratory rate
  • Optical sensor system with software algorithms
  • AI-powered data analysis
  • Provides actionable physiological insights
  • Remote monitoring capabilities
  • Non-invasive measurement
  • Spot-measurement tool (not continuous monitoring)
  • Designed for healthcare professional supervision

Use Cases

  • Health monitoring in homecare and elderly care
  • Telemedicine applications
  • General clinical care
  • Disease tracking and management
  • Clinical research
  • Use in hospital and outpatient settings

What Physicians Need to Know

Heart Failure Risk Prediction
The Gili Pro BioSensor is designed for the early detection of lung congestion, a key indicator of heart failure exacerbation, to help prevent hospitalizations. It utilizes AI-based analysis of nano-vibrations from the patient's chest to detect signs of pulmonary congestion and other parameters relevant to heart failure. In a study, the system achieved a sensitivity and specificity of 0.91 for detecting pulmonary congestion, with an accuracy of 91%.
Cardiac Monitoring Integration
The Gili Pro BioSensor is a contact-free optical system that measures chest motion vibrations to identify cardiopulmonary parameters. It is designed for remote patient monitoring in the home, offering a user-friendly, pre-emptive approach to cardiac and pulmonary health monitoring.
Real-Time Alert Capability
The AI-based system delivers clinically meaningful insights and notifications of changes in key health indicators. This enables a pre-emptive approach to cardiac and pulmonary health monitoring.
Physician Tip

The Gili Pro BioSensor offers a non-invasive, contact-free method for monitoring key cardiac and pulmonary biomarkers, particularly useful for patients with congestive heart failure (CHF) and other chronic cardiopulmonary diseases. Its ability to detect early signs of lung congestion with high accuracy (91% sensitivity and specificity) can aid in preventing hospital readmissions. The system provides real-time alerts for changes in health indicators, allowing for timely intervention. Physicians should note that the device is intended for use by or under the supervision of healthcare professionals for adult patients in various medical settings or for clinical research. Patients need to be compliant with the measurement procedure, remaining still and refraining from talking during the examination.

The Gili Pro BioSensor is a standalone contact-free optical system. Information regarding direct EHR integrations is not explicitly provided. However, its design for remote patient monitoring and delivery of clinically meaningful insights suggests potential for data export or integration with broader telehealth platforms. The system is compatible with mobile/tablet (native app) and desktop hardware.

Details

Category Cardiology AI, Wearables & Remote Monitoring (RPM)
Pricing Unknown
DeploymentMobile / Tablet (native app), Desktop
Mobile App1
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated

The Gili Pro BioSensor (also known as "Gili BioSensor System") received FDA De Novo clearance (DEN200038) on April 8, 2021, for hardware and software for optical camera-based measurement of pulse rate, heart rate, breathing rate, and/or respiratory rate. The device is indicated for use by or under the supervision of healthcare professionals for adult patients in a hospital, outpatient, or other medical care settings, or for clinical research purposes. It is a prescription device. Donisi is working to expand the clinical scope of the Gili system and plans to submit for clearance for at-home identification of pulmonary congestion.

Integrations
EHR Not specified
Specialties Cardiology, Critical Care, Pulmonology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2021-04-01DEN200038 De NovoGili Pro BioSensor (also known as “Gili BioSensor System”)

What the Web Says

The Gili Pro BioSensor, also known as the Gili BioSensor System, is a contact-free optical device developed by ContinUse Biometrics (now Donisi Health) that uses light waves and AI algorithms to detect various cardiopulmonary parameters, including heart rate, respiratory rate, and irregular heart rhythms. It has received FDA clearance for spot-measurement of heart rate and respiratory rate and has been studied for its efficacy in detecting lung congestion and atrial fibrillation. The system is designed for remote, effortless, and non-touch physiological monitoring, aiming to provide continuous medical monitoring in various settings like clinics, homes, and workplaces.

Overall: Positive

Strengths

  • Contact-free and non-invasive, enhancing patient comfort and reducing infection risk.
  • FDA-cleared for spot-measurement of heart rate and respiratory rate.
  • Demonstrated high accuracy in detecting lung congestion and atrial fibrillation in studies.
  • Utilizes AI and machine learning for data analysis and accurate physiological assessment.
  • Potential for use in telemedicine and remote patient monitoring, reducing hospitalizations.
  • Capable of measuring patients with diverse BMIs, chest shapes, skin pigmentation, and clothing layers.

Limitations

  • Primarily intended for spot-measurement rather than continuous monitoring.
  • Requires the patient to remain still and compliant with the measurement procedure.
  • Limited information available from independent tech reviewers, Reddit, G2, or Capterra.
  • While studies show efficacy, further validation across larger and more precise scales is warranted for some applications like lung congestion detection.

Based on reviews from: researchgate.net, aviahealth.com, liberty.edu, nih.gov, fintastico.com, oup.com, clinicaltrials.gov, scribd.com, fda.gov

Last updated: 2026-10-29

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Gili Pro BioSensor (also known as Gili BioSensor System)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

researchgate.net
Continuse Biometrics Gili Biosensor System
The Gili Biosensor System by Continuse Biometrics is mentioned in a report on Digital Health Trends 2024 as an optical/camera measurement device for heart and respiratory rates/function, categorized under vitals monitoring. It is also listed as an adjunctive diagnosis device for skin cancer in oncology.
2002-12
nih.gov
US Food and Drug Administration (FDA) approved AI-based medical device for respiratory disease detection and diagnostic
The Gili Pro Biosensor from Continuse Biometrics Ltd. received FDA approval on April 1, 2021, under De Novo number DEN200038, for respiratory rate measurement using Near-Infrared (NIR) technology.
2024-08
oup.com
Development and validation of a novel artificial intelligence-based algorithm for the detection of atrial fibrillation from a contact-free optical sensor
This study details the development and evaluation of an AI-based algorithm for atrial fibrillation detection using the Gili Pro BioSensor, an FDA-cleared, contact-free optical system. The device measures motion-vibration data and has been validated across various patient demographics and conditions for spot-measurement of heart and respiratory rates.
2022-12
issuu.com
The Big 100: Medical Device Companies
The Gili Pro BioSensor is listed among medical devices, noted for its use of an optical sensor system and software algorithms to estimate vital signs, although the publicly available Reclassification Order did not explicitly mention "machine learning" or "artificial intelligence."
2021-11

Videos

Product demos, reviews, and walkthroughs for Gili Pro BioSensor (also known as Gili BioSensor System).

Loading videos...

View all on YouTube

Frequently Asked Questions

The Gili Pro BioSensor, also known as the Gili BioSensor System, is a contact-free optical system that uses light waves (nano-vibration motion detection) to measure physiological information. It is intended for use by healthcare professionals to assess heart rate and respiratory rate in adult patients in various medical settings. The system captures motion-vibration signals from an illuminated surface and analyzes them using proprietary algorithms and AI.
The Gili Pro BioSensor received FDA clearance as a Class II prescription device in April 2021. It is classified as hardware and software for optical camera-based measurement of pulse rate, heart rate, breathing rate, and/or respiratory rate. As a prescription device, it must comply with 21 CFR 801.109. The FDA requires comprehensive software descriptions, verification and validation testing, hazard analysis, risk assessment, and cybersecurity vulnerability management for such devices.
Studies have shown the Gili BioSensor System to be effective in detecting lung congestion, a key indicator in heart failure exacerbation. In a study with 227 patients, the system achieved a sensitivity and specificity of 0.91 (91%) for detecting lung congestion. This contact-free infrared optical solution provides medical-grade monitoring for pulmonary congestion, with its accuracy not being affected by various covariates like respiratory or valvular conditions.
The Gili Pro BioSensor is a prescription device indicated for use by or under the supervision of healthcare professionals. It is not intended to independently direct therapy. The device requires the subject to be seated upright either in a chair or in a bed during measurements. Additionally, patients must remain still and refrain from talking during the examination for accurate readings. Like all AI-powered systems, its effectiveness relies on the quality of data it's trained on, and there's a risk of misinterpreting subtle abnormalities if data is incomplete or biased.
Yes, there are numerous AI-powered cardiac monitoring solutions available, with cardiology being a leading specialty for FDA-cleared AI algorithms. These alternatives include wearable devices, AI for ECG analysis, cardiac imaging, and remote monitoring platforms. The Gili Pro BioSensor differentiates itself as a contact-free solution that uses light waves for simultaneous detection of cardiac and pulmonary health biomarkers, aiming to provide early detection of lung congestion to prevent rehospitalizations in CHF patients.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-05 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.